Sandbox: Maria 15: Difference between revisions
Created page with "__NOTOC__ {{SI}} {{CMG}} {{AE}} {{MV}} {{SK}} HFpEF; Heart Failure with Preserved Ejection Fraction; HFnE..." |
No edit summary |
||
| Line 2: | Line 2: | ||
{{SI}} | {{SI}} | ||
{{CMG}} {{AE}} {{MV}} | {{CMG}} {{AE}} {{MV}} | ||
{{SK}} HFpEF; Heart Failure with Preserved Ejection Fraction; HFnEF; Heart Failure with a Normal Ejection Fraction; DHF; Diastolic Heart Failure | |||
==Overview== | |||
==Historical Perspective== | |||
*Heart failure with preserved ejection fraction was first discovered by | |||
==Classification== | |||
==Pathophysiology== | |||
==Causes== | |||
* '''To see a comprehensive list of all causes of heart failure, please click [[Heart failure causes|here]]''' | |||
==Epidemiology and Demographics== | |||
===Age=== | |||
===Gender=== | |||
===Race=== | |||
==Risk Factors== | |||
*Common risk factors in the development of | |||
== Natural History, Complications and Prognosis== | |||
*The majority of patients with leukocytosis are initially symptomatic. | |||
*Early clinical features, include: | |||
*Common complications of leukocytosis, include: | |||
== Diagnosis == | |||
{{ | === Symptoms === | ||
=== Laboratory Findings === | |||
*Laboratory findings consistent with the diagnosis of HFpEF, include: | |||
== Treatment == | |||
=== Medical Therapy === | |||
==References== | |||
{{Reflist|2}} | |||
[[Category:Laboratory Test]] | |||
[[Category:Hematology]] | |||
[[Category:Infectious disease]] | |||
[[Category:Blood tests]] | |||
[[Category:Overview complete]] | |||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
Revision as of 21:31, 25 July 2016
|
WikiDoc Resources for Sandbox: Maria 15 |
|
Articles |
|---|
|
Most recent articles on Sandbox: Maria 15 Most cited articles on Sandbox: Maria 15 |
|
Media |
|
Powerpoint slides on Sandbox: Maria 15 |
|
Evidence Based Medicine |
|
Cochrane Collaboration on Sandbox: Maria 15 |
|
Clinical Trials |
|
Ongoing Trials on Sandbox: Maria 15 at Clinical Trials.gov Trial results on Sandbox: Maria 15 Clinical Trials on Sandbox: Maria 15 at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Sandbox: Maria 15 NICE Guidance on Sandbox: Maria 15
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Sandbox: Maria 15 Discussion groups on Sandbox: Maria 15 Patient Handouts on Sandbox: Maria 15 Directions to Hospitals Treating Sandbox: Maria 15 Risk calculators and risk factors for Sandbox: Maria 15
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Sandbox: Maria 15 |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2] Synonyms and keywords: HFpEF; Heart Failure with Preserved Ejection Fraction; HFnEF; Heart Failure with a Normal Ejection Fraction; DHF; Diastolic Heart Failure
Overview
Historical Perspective
- Heart failure with preserved ejection fraction was first discovered by
Classification
Pathophysiology
Causes
- To see a comprehensive list of all causes of heart failure, please click here
Epidemiology and Demographics
Age
Gender
Race
Risk Factors
- Common risk factors in the development of
Natural History, Complications and Prognosis
- The majority of patients with leukocytosis are initially symptomatic.
- Early clinical features, include:
- Common complications of leukocytosis, include:
Diagnosis
Symptoms
Laboratory Findings
- Laboratory findings consistent with the diagnosis of HFpEF, include: